This company has been acquired
BELLUS Health Croissance future
Future contrôle des critères 2/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for BELLUS Health.
Informations clés
46.1%
Taux de croissance des bénéfices
41.4%
Taux de croissance du BPA
Biotechs croissance des bénéfices | 36.5% |
Taux de croissance des recettes | 69.0% |
Rendement futur des capitaux propres | n/a |
Couverture par les analystes | Low |
Dernière mise à jour | 16 Jun 2023 |
Mises à jour récentes de la croissance future
Recent updates
BELLUS Health (TSE:BLU) Is In A Good Position To Deliver On Growth Plans
Jan 16Here's Why We're Not Too Worried About BELLUS Health's (TSE:BLU) Cash Burn Situation
Sep 07We're Hopeful That BELLUS Health (TSE:BLU) Will Use Its Cash Wisely
May 05Here's Why We're Watching BELLUS Health's (TSE:BLU) Cash Burn Situation
Jan 06Companies Like BELLUS Health (TSE:BLU) Are In A Position To Invest In Growth
Sep 10Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
12/31/2025 | 40 | -147 | -110 | -64 | 3 |
12/31/2024 | 0 | -141 | -130 | -127 | 3 |
12/31/2023 | 0 | -117 | -125 | -101 | 2 |
3/31/2023 | 0 | -87 | -89 | -89 | N/A |
12/31/2022 | 0 | -76 | -77 | -77 | N/A |
9/30/2022 | 0 | -73 | -68 | -68 | N/A |
6/30/2022 | 0 | -71 | -64 | -64 | N/A |
3/31/2022 | 0 | -70 | -60 | -60 | N/A |
12/31/2021 | 0 | -71 | -61 | -61 | N/A |
9/30/2021 | 0 | -64 | -49 | -49 | N/A |
6/30/2021 | 0 | -47 | -40 | -40 | N/A |
3/31/2021 | 0 | -37 | -36 | -36 | N/A |
12/31/2020 | 0 | -32 | -30 | -30 | N/A |
9/30/2020 | 0 | -34 | -30 | -30 | N/A |
6/30/2020 | 0 | -35 | -32 | -32 | N/A |
3/31/2020 | 0 | -33 | -29 | -29 | N/A |
12/31/2019 | 0 | -26 | -21 | -21 | N/A |
9/30/2019 | 0 | -18 | -14 | -14 | N/A |
6/30/2019 | 0 | -14 | -9 | -9 | N/A |
3/31/2019 | 0 | -9 | -8 | -8 | N/A |
12/31/2018 | 0 | -7 | -7 | -7 | N/A |
9/30/2018 | 0 | -6 | -7 | -7 | N/A |
6/30/2018 | 0 | -5 | -6 | -6 | N/A |
3/31/2018 | 0 | -4 | -5 | -5 | N/A |
12/31/2017 | 0 | -1 | -5 | -3 | N/A |
9/30/2017 | 0 | -1 | -4 | -3 | N/A |
6/30/2017 | 1 | 0 | -3 | -2 | N/A |
3/31/2017 | 1 | 0 | -3 | -2 | N/A |
12/31/2016 | 1 | -2 | N/A | -2 | N/A |
9/30/2016 | 3 | -1 | N/A | -2 | N/A |
6/30/2016 | 3 | 0 | N/A | -2 | N/A |
3/31/2016 | 3 | 0 | N/A | -2 | N/A |
12/31/2015 | 3 | 0 | N/A | -2 | N/A |
9/30/2015 | 2 | 0 | N/A | -2 | N/A |
6/30/2015 | 2 | -1 | N/A | -2 | N/A |
3/31/2015 | 2 | -1 | N/A | -2 | N/A |
12/31/2014 | 2 | -2 | N/A | -3 | N/A |
9/30/2014 | 2 | -2 | N/A | -3 | N/A |
6/30/2014 | 2 | -1 | N/A | -4 | N/A |
3/31/2014 | 2 | -1 | N/A | -3 | N/A |
12/31/2013 | 2 | -1 | N/A | -3 | N/A |
9/30/2013 | 2 | -1 | N/A | -3 | N/A |
6/30/2013 | 2 | -2 | N/A | -3 | N/A |
3/31/2013 | 2 | -10 | N/A | -3 | N/A |
12/31/2012 | 2 | -13 | N/A | -3 | N/A |
9/30/2012 | 3 | -15 | N/A | -2 | N/A |
6/30/2012 | 3 | -14 | N/A | -2 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: BLU is forecast to remain unprofitable over the next 3 years.
Bénéfices vs marché: BLU is forecast to remain unprofitable over the next 3 years.
Croissance élevée des bénéfices: BLU is forecast to remain unprofitable over the next 3 years.
Chiffre d'affaires vs marché: BLU's revenue (69% per year) is forecast to grow faster than the Canadian market (5.3% per year).
Croissance élevée des revenus: BLU's revenue (69% per year) is forecast to grow faster than 20% per year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Insufficient data to determine if BLU's Return on Equity is forecast to be high in 3 years time